Primary Biliary Cholangitis Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
GNFT | A | GENFIT S.A. | 0.51 | |
MIRM | B | Mirum Pharmaceuticals, Inc. | 5.04 | |
THAR | D | Tharimmune, Inc. | -5.61 |
Related Industries: Biotechnology
Related ETFs - A few ETFs which own one or more of the above listed Primary Biliary Cholangitis stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
BBP | A | BioShares Biotechnology Products Fund | 2.19 | |
HRTS | D | Tema Cardiovascular and Metabolic ETF | 2.08 | |
SBIO | B | ALPS Medical Breakthroughs ETF | 1.25 | |
ILDR | B | First Trust Innovation Leaders ETF | 0.6 | |
FYC | A | First Trust Small Cap Growth AlphaDEX Fund | 0.51 |
Compare ETFs
Related Industries:
Biotechnology
- Primary Biliary Cholangitis
Primary Biliary Cholangitis (PBC) is a chronic, progressive autoimmune liver disease that affects the small bile ducts in the liver. It is caused by an immune system attack on the bile ducts, leading to inflammation, scarring, and eventual destruction of the ducts. Symptoms of PBC include fatigue, itching, jaundice, and abdominal pain. Treatment typically involves medications to reduce inflammation and slow the progression of the disease.
Popular Now
Recent Comments
- Cos3 on Adding float as advanced filter criteria?
- FriendlyOyster657 on BOOT
- TraderMike on Filtering by News?
- Dr_Duru on Filtering by News?
- TraderMike on Filtering by News?
From the Blog
Featured Articles